Molecular design of dual inhibitors of PI3K and potential molecular target of cancer for its treatment: A review
Author:
Publisher
Elsevier BV
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference130 articles.
1. Network pharmacology: the next paradigm in drug discovery;Hopkins;Nat. Chem. Biol.,2008
2. Multitarget Drug Discovery and Polypharmacology, ChemMedChem;Bolognesi,2016
3. Exploiting polypharmacology for improving therapeutic outcome of kinase inhibitors (KIs): an update of recent medicinal chemistry efforts;Ma;Eur. J. Med. Chem.,2018
4. Polypharmacology by design: a medicinal chemist's perspective on multitargeting compounds;Proschak;J. Med. Chem.,2018
5. Polypharmacology: drug discovery for the future;Reddy;Expet Rev. Clin. Pharmacol.,2013
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A comprehensive review of small molecules targeting PI3K pathway: Exploring the structural development for the treatment of breast cancer;Bioorganic Chemistry;2024-02
2. Discovery of benzamide-based PI3K/HDAC dual inhibitors with marked pro-apoptosis activity in lymphoma cells;European Journal of Medicinal Chemistry;2023-12
3. Novel 5-aminopyrazoles endowed with anti-angiogenetic properties: Design, synthesis and biological evaluation;European Journal of Medicinal Chemistry;2023-11
4. Azaindole derivatives as potential kinase inhibitors and their SARs elucidation;European Journal of Medicinal Chemistry;2023-10
5. Therapeutic strategies of dual-target small molecules to overcome drug resistance in cancer therapy;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3